Baxion
Screening
Tags
Alerts
Theme
Elite Pharmaceuticals Inc.
ELTP
·
OTC
·
$0.35
Share Price as of 11/2
·
$374M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q1 ended 06/30/26
08/13/26
10-K
FY 2026
06/29/26
10-Q
Q3 ended 12/31/25
02/17/26
10-Q
Q2 ended 09/30/25
11/14/25
10-Q
Q1 ended 06/30/25
08/14/25
Disclosures
Filter
8-K
Current report
08/13/26
8-K/A
Current report (amended)
08/11/26
8-K
Current report
08/10/26
8-K
Current report
08/04/26
8-K
Current report
06/29/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
07/01/24
S-8
Registration of securities for employees
03/28/24
S-8
Registration of securities for employees
03/28/24
424B3
Prospectus
07/27/20
S-3
Shelf registration
07/15/20
Proxies
Filter
DEFA14A
Additional proxy materials
05/11/20
DEF 14A
Definitive proxy
04/29/20
PRE 14A
Preliminary proxy
04/17/20
DEFA14A
Additional proxy materials
10/18/19
DEF 14A
Definitive proxy
10/10/19
Ownership
Filter
Form 4
Insider transaction
10/19/26
Form 4
Insider transaction
09/10/26
Form 4
Insider transaction
01/13/26
Form 4
Plassche Douglas
10/03/25
Form 4
Elite Pharmaceuticals INC /nv/
08/26/25
Other
Filter
UPLOAD
Letter from the SEC
04/14/26
CORRESP
Correspondence with the SEC
03/18/26
UPLOAD
Letter from the SEC
03/04/26
UPLOAD
Letter from the SEC
02/28/24
CORRESP
Correspondence with the SEC
02/20/24
Latest Filings
Filter
10-Q
Q1 ended 06/30/26
08/13/26
8-K
Current report
08/13/26
8-K/A
Current report (amended)
08/11/26
8-K
Current report
08/10/26
8-K
Current report
08/04/26
Ownership
Filter
Form 4
Insider transaction
10/19/26
Form 4
Insider transaction
09/10/26
Form 4
Insider transaction
01/13/26
Form 4
Plassche Douglas
10/03/25
Form 4
Elite Pharmaceuticals INC /nv/
08/26/25